fda glp-1 warning letters october 2025 news The sent a letter to the maker of Ozempic and Wegovy over unreported potential side effects. Here's what to know Congress Introduces SAFE Drugs Act

Many people attribute these symptoms to the GLP-1 medication itself when the real culprit is a correctable nutrient deficiency

Microdosing may seem like a gentle or easier approach, but it often leads to disappointing results or unnecessary risks

Study of anti-inflammatory activity of Tibetan mushroom, a symbiotic culture of bacteria and fungi encapsulated into a polysaccharide matrix

Results can vary

Finally, autophagy and/or mitophagy mechanisms act against cellular oxidative stress (Filomeni et al

For example, 15 states cover Wegovy for obesity in the state employee plan, while 14 states cover it in Medicaid